The clinical significance of CD169-positive lymph node macrophage in patients with breast cancer

PLoS ONE

Volumn 11, Issue 11, 2016, Pages

  Shiota, Takuya ^a   Miyasato, Yuko ^a   Ohnishi, Koji ^a   Yamamoto Ibusuki, Mutsuko ^b   Yamamoto, Yutaka ^a   Iwase, Hirotaka ^a   Takeya, Motohiro ^a   Komohara, Yoshihiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; KI 67 ANTIGEN; PARAFFIN; SIALOADHESIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CD8+ T LYMPHOCYTE; CELL DENSITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISTANT RELAPSE FREE SURVIVAL; EARLY CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE; LYMPH NODE CELL; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; MACROPHAGE; MAJOR CLINICAL STUDY; MIDDLE AGED; RECURRENCE FREE SURVIVAL; REGIONAL LYMPH NODE; TUMOR VOLUME; BREAST NEOPLASMS; FOLLOW UP; IMMUNOLOGY; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; YOUNG ADULT;

ADULT; BIOMARKERS; BREAST NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MACROPHAGES; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SIALIC ACID BINDING IG-LIKE LECTIN 1; SURVIVAL ANALYSIS; TUMOR BURDEN; YOUNG ADULT;

EID: 84995960293     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0166680     Document Type: Article

References (32)

1. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378: 1707-16. doi: 10.1016/S0140-6736(11)61629-2 PMID: 22019144
2. Rose BS, Jiang W, Punglia RS. Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer. Breast Cancer Res Treat. 2015; 152: 209-16. doi: 10.1007/s10549-015-3451-y PMID: 26041688
3. Vicente Conesa MA, Garcia-Martinez E, Gonzalez Billalabeitia E, Chaves Benito A, Garcia Garcia T, Vicente Garcia V, et al. Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy. Breast. 2012; 21: 468-74. doi: 10.1016/j.breast.2011.11.002 PMID: 22119767
4. Kim ST, Jeong H, Woo OH, Seo JH, Kim A, Lee ES, et al. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer. Am J Clin Oncol. 2013; 36: 224-31. doi: 10.1097/COC.0b013e3182467d90 PMID: 22495453
5. + cells is characteristic for the medullary subtype. Histopathology. 2011; 59: 965-74. doi: 10.1111/j.1365-2559.2011.04040.x PMID: 22092408
6. Denkert C, Loibl S, Noske A, Roller M, Müller BM, Komor M, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol. 2010; 28: 105-13. doi: 10.1200/JCO.2009.23.7370 PMID: 19917869
7. Takahashi R, Toh U, Iwakuma N, Takenaka M, Otsuka H, Furukawa M, et al. Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients. Breast Cancer Res. 2014; 16: R70. doi: 10.1186/bcr3685 PMID: 24992895
8. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010; 32: 593-604. doi: 10.1016/j.immuni.2010.05.007 PMID: 20510870
9. Mills CD. Anatomy of a discovery: m1 and m2 macrophages. Front Immunol. 2015; 6: 212. doi: 10.3389/fimmu.2015.00212 PMID: 25999950
10. Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee PP. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med. 2005; 2: e284. doi: 10.1371/journal. pmed.0020284 PMID: 16124834
11. Grotz TE, Jakub JW, Mansfield AS, Goldenstein R, Enninga EA, Nevala WK, et al. Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma. Oncoimmunology. 2015; 4: e1026504. doi: 10.1080/2162402X.2015.1026504 PMID: 26405583
12. Asano K, Nabeyama A, Miyake Y, Qiu CH, Kurita A, Tomura M, et al. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity. 2011; 34: 85-95. doi: 10.1016/j.immuni.2010.12.011 PMID: 21194983
13. + macrophages at the crossroads of antigen presentation. Trends Immunol. 2012; 33: 66-70. doi: 10.1016/j.it.2011.11.001 PMID: 22192781
14. Kuka M, Iannacone M. The role of lymph node sinus macrophages in host defense. Ann N Y Acad Sci. 2014; 1319: 38-46. doi: 10.1111/nyas.12387 PMID: 24592818
15. Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood. 2001; 97: 288-96. PMID: 11133773
16. Ravishankar B, Shinde R, Liu H, Chaudhary K, Bradley J, Lemos HP, et al. Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance. Proc Natl Acad Sci U S A. 2014; 111: 4215-20. doi: 10.1073/pnas.1320924111 PMID: 24591636
17. Prestwood TR, May MM, Plummer EM, Morar MM, Yauch LE, Shresta S. Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice. J Virol. 2012; 86: 12138-47. doi: 10.1128/JVI.00375-12 PMID: 22933295
18. Ohnishi K, Komohara Y, Saito Y, Miyamoto Y, Watanabe M, Baba H, et al. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. Cancer Sci. 2013; 104: 1237-44. doi: 10.1111/cas.12212 PMID: 23734742
19. Yamamoto-Ibusuki M, Yamamoto Y, Yamamoto S, Fujiwara S, Fu P, Honda Y, et al. Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 and the corresponding gene expression score in breast cancer. Mod Pathol. 2013; 26: 79-86. doi: 10.1038/modpathol.2012.151 PMID: 22918168
20. Xu C, Yamamoto-Ibusuki M, Yamamoto Y, Yamamoto S, Fujiwara S, Murakami K, et al. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Breast Cancer. 2014; 21: 482-90. doi: 10.1007/s12282-012-0403-9 PMID: 22968628
21. Saito Y, Ohnishi K, Miyashita A, Nakahara S, Fujiwara Y, Horlad H, et al. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma. Cancer Immunol Res. 2015; 3: 1356-63. doi: 10.1158/2326-6066.CIR-14-0180 PMID: 26297710
22. Bernhard CA, Ried C, Kochanek S, Brocker T. CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells. Proc Natl Acad Sci U S A. 2015; 112: 5461-6. doi: 10.1073/pnas.1423356112 PMID: 25922518
23. Wu C, Rauch U, Korpos E, Song J, Loser K, Crocker PR, et al. Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression. J Immunol. 2009 15; 182: 6508-16. doi: 10.4049/jimmunol.0804247 PMID: 19414805
24. Barral P, Polzella P, Bruckbauer A, van Rooijen N, Besra GS, Cerundolo V, et al. CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol. 2010; 11: 303-12. doi: 10.1038/ni.1853 PMID: 20228797
25. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998; 58: 3491-4. PMID: 9721846
26. Sharma P, Shen Y, Wen S, Yamada S, Jungbluth AA, Gnjatic S, et al. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci U S A. 2007; 104: 3967-72. doi: 10.1073/pnas.0611618104 PMID: 17360461
27. Brown JR, Wimberly H, Lannin DR, Nixon C, Rimm DL, Bossuyt V. Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer. Clin Cancer Res. 2014; 20: 5995-6005. doi: 10.1158/1078-0432.CCR-14-1622 PMID: 25255793
28. Miyashita M, Sasano H, Tamaki K, Chan M, Hirakawa H, Suzuki A, et al. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat. 2014; 148: 525-34. doi: 10.1007/s10549-014-3197-y PMID: 25395319
29. Liu Y, Komohara Y, Domenick N, Ohno M, Ikeura M, Hamilton RL, et al. Expression of antigen processing and presenting molecules in brain metastasis of breast cancer. Cancer Immunol Immunother. 2012; 61:789-801. doi: 10.1007/s00262-011-1137-9 PMID: 22065046
30. Ménard S, Tomasic G, Casalini P, Balsari A, Pilotti S, Cascinelli N, et al. Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res. 1997; 3: 817-9. PMID: 9815754
31. + lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer. Breast Cancer Res. 2012; 14: R48. doi: 10.1186/bcr3148 PMID: 22420471
32. Sabatier R, Finetti P, Mamessier E, Adelaide J, Chaffanet M, Ali HR, et al. Prognostic and predictive value of PDL1 expression in breast cancer. Oncotarget. 2015; 6: 5449-64. doi: 10.18632/oncotarget. 3216 PMID: 25669979